Llwytho...
AXL receptor tyrosine kinase as a therapeutic target in NSCLC
The AXL receptor tyrosine kinase and its ligand, Gas6, regulate key processes in lung cancer growth, metastasis, and epithelial–mesenchymal transition-associated drug resistance. Gas6 and AXL expression have been correlated with poor prognosis and advanced clinical stage in patients with lung cancer...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Lung Cancer (Auckl) |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217513/ https://ncbi.nlm.nih.gov/pubmed/28210148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S60438 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|